YAP/TAZ signaling and resistance to cancer therapy

CDK Nguyen, C Yi - Trends in cancer, 2019 - cell.com
Drug resistance is a major challenge in cancer treatment. Emerging evidence indicates that
deregulation of YAP/TAZ signaling may be a major mechanism of intrinsic and acquired …

Hippo signaling in the ovary: emerging roles in development, fertility, and disease

KL Clark, JW George, E Przygrodzka… - Endocrine …, 2022 - academic.oup.com
Emerging studies indicate that the Hippo pathway, a highly conserved pathway that
regulates organ size control, plays an important role in governing ovarian physiology …

Recent advances of the Hippo/YAP signaling pathway in brain development and glioma

T Ouyang, W Meng, M Li, T Hong, N Zhang - Cellular and molecular …, 2020 - Springer
The Hippo signaling pathway is highly conserved from Drosophila melanogaster to
mammals and plays a crucial role in organ size control, tissue regeneration, and tumor …

[HTML][HTML] Action mechanism of metformin and its application in hematological malignancy treatments: a review

Y Zhang, F Zhou, J Guan, L Zhou, B Chen - Biomolecules, 2023 - mdpi.com
Hematologic malignancies (HMs) mainly include acute and chronic leukemia, lymphoma,
myeloma and other heterogeneous tumors that seriously threaten human life and health …

Metformin: review of epidemiology and mechanisms of action in pancreatic cancer

G Eibl, E Rozengurt - Cancer and Metastasis Reviews, 2021 - Springer
Pancreatic ductal adenocarcinoma continues to be a lethal disease, for which efficient
treatment options are very limited. Increasing efforts have been taken to understand how to …

Combination of metformin with chemotherapeutic drugs via different molecular mechanisms

M Peng, KO Darko, T Tao, Y Huang, Q Su, C He… - Cancer treatment …, 2017 - Elsevier
Metformin, a widely prescribed drug for treating type II diabetes, is one of the most
extensively recognized metabolic modulators which has shown an important anti-cancer …

[HTML][HTML] Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells

Y Wu, Q Zheng, Y Li, G Wang, S Gao, X Zhang… - Journal of Experimental …, 2019 - Springer
Background Metformin has been reported to function as the anti-tumor inhibiting the growth
of different types of cancers, including bladder cancer. But there are few reports on the roles …

[HTML][HTML] The ambivalent function of YAP in apoptosis and cancer

X Zhang, A Abdelrahman, B Vollmar… - International journal of …, 2018 - mdpi.com
Yes-associated protein, a core regulator of the Hippo-YAP signaling pathway, plays a vital
role in inhibiting apoptosis. Thus, several studies and reviews suggest that yes-associated …

[HTML][HTML] Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus

CH Tseng - Aging (Albany NY), 2016 - ncbi.nlm.nih.gov
This retrospective cohort study investigated whether metformin may reduce gastric cancer
risk by using the reimbursement databases of the Taiwan's National Health Insurance …

[HTML][HTML] The role of AMP-activated protein kinase as a potential target of treatment of hepatocellular carcinoma

X Jiang, HY Tan, S Teng, YT Chan, D Wang, N Wang - Cancers, 2019 - mdpi.com
Background: Hepatocellular carcinoma (HCC) is the fifth most frequent cancer worldwide
with a very high recurrence rate and very dismal prognosis. Diagnosis and treatment in HCC …